Movatterモバイル変換


[0]ホーム

URL:


CN104311544A - Preparation method of benzoxazole derivative - Google Patents

Preparation method of benzoxazole derivative
Download PDF

Info

Publication number
CN104311544A
CN104311544ACN201410482468.9ACN201410482468ACN104311544ACN 104311544 ACN104311544 ACN 104311544ACN 201410482468 ACN201410482468 ACN 201410482468ACN 104311544 ACN104311544 ACN 104311544A
Authority
CN
China
Prior art keywords
compound
reaction
xylol
temperature
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410482468.9A
Other languages
Chinese (zh)
Inventor
陈芳军
邓泽平
李书耘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Huateng Pharmaceutical Co Ltd
Original Assignee
Hunan Huateng Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan Huateng Pharmaceutical Co LtdfiledCriticalHunan Huateng Pharmaceutical Co Ltd
Priority to CN201410482468.9ApriorityCriticalpatent/CN104311544A/en
Publication of CN104311544ApublicationCriticalpatent/CN104311544A/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The invention discloses a preparation method of a benzoxazole derivative (1-(5-bromo[d] oxazole-2-yl) piperidine-4-yl) methylamine. A starting material 2-amino-4-bromophenol is subjected to cyclization, chlorination, nucleophilic substitution, aminolysis and reduction to obtain the target product. The compound is an important pharmaceutical intermediate.

Description

A kind of preparation method of benzoxazoles derivative
Technical field
The present invention relates to a kind of novel processing step of medicine intermediate, particularly a kind of preparation method of a kind of preparation method of (1-(5-bromobenzene is [d] oxazole-2-base also) piperidin-4-yl) methylamine.
Technical background
Compound (1-(5-bromobenzene is [d] oxazole-2-base also) piperidin-4-yl) methylamine, structural formula is:
This compound (1-(5-bromobenzene is [d] oxazole-2-base also) piperidin-4-yl) methylamine and relevant derivative have widespread use in pharmaceutical chemistry and organic synthesis.The synthesis of (1-(5-bromobenzene is [d] oxazole-2-base also) piperidin-4-yl) methylamine is comparatively difficult at present.Therefore, need exploitation raw material to be easy to get, easy to operate, reaction is easy to control, the synthetic method that overall yield is suitable.
Summary of the invention
The invention discloses the method that one prepares (1-(5-bromobenzene is [d] oxazole-2-base also) piperidin-4-yl) methylamine, with 2-amino-4-bromophenol for starting raw material, obtain target product 6 through the ring that reaches a standard, chloro, nucleophilic substitution, ammonia solution, reduction, synthetic route as shown in Figure 1.Synthesis step is as follows:
(1) with 2-amino-4-bromophenol for starting raw material, obtain 2 through ring closure reaction;
(2) carry out chlorination 2, obtain 3;
(3) carry out nucleophilic substitution reaction 3 and obtain 4;
(4) carry out ammonolysis reaction 4 and obtain target product 5,
(5) carry out reduction reaction 5 and obtain target product 6,
One preferred embodiment in, the reagent that described ring closure reaction prepares compound 2 used is selected from potassium ethyl xanthonate; The reagent that described chlorination prepares compound 3 used is selected from chlorine; The alkali that described nucleophilic substitution reaction prepares compound 4 used is selected from salt of wormwood; The reagent that described ammonolysis reaction prepares compound 5 used is selected from ammoniacal liquor; The reductive agent that described reduction reaction prepares compound 6 used is selected from lithium aluminium hydride.
One preferred embodiment in, the solvent that described ring closure reaction prepares compound 2 used is selected from pyridine; The solvent that described chlorination prepares compound 3 used is selected from trichloromethane; The solvent that described nucleophilic substitution reaction prepares compound 4 used is selected from DMF; The solvent that described ammonolysis reaction prepares compound 5 used is selected from tetrahydrofuran (THF); The solvent that described reduction reaction prepares compound 6 used is selected from tetrahydrofuran (THF).
One preferred embodiment in, described ring closure reaction prepares the reflux temperature that compound 2 temperature of reaction used is solvent; It is 0 DEG C ~ room temperature that described chlorination prepares compound 3 temperature used; Described nucleophilic substitution reaction prepares the reflux temperature that compound 4 temperature used is solvent; Described ammonolysis reaction prepare compound 5 used be room temperature; It is 0 DEG C ~ room temperature that described reduction reaction prepares compound 6 temperature used.
The present invention relates to the preparation method of one (1-(5-bromobenzene is [d] oxazole-2-base also) piperidin-4-yl) methylamine, there is no other Patents bibliographical informations at present.
Accompanying drawing explanation
Fig. 1 is the synthetic route chart of compound (1-(5-bromobenzene is [d] oxazole-2-base also) piperidin-4-yl) methylamine.
The present invention is further described by the following embodiment, and these descriptions are not be further limited content of the present invention.One skilled in the art will understand that the equivalent replacement that technical characteristic of the present invention is done, or improve accordingly, still belong within protection scope of the present invention.
Specific embodiment mode
Embodiment 1
(1) synthesis of 5-bromobenzene also [d] oxazole-2-mercaptan potassium
40g 2-amino-4-bromophenol is joined in 380ml pyridine, add 63g potassium ethyl xanthonate, reflux stirs 5 hours, the most of pyridine of concentrated removing, add dilute hydrochloric acid and ethyl acetate, separatory, collection organic phase, dry, concentrated, residuum upper prop is separated and obtains 51g 5-bromobenzene also [d] oxazole-2-mercaptan potassium.
(2) synthesis of the bromo-2-chlorobenzene of 5-also [d] oxazole
50g 5-bromobenzene also [d] oxazole-2-mercaptan potassium join in 1000ml chloroform, be cooled to 0 DEG C, pass into chlorine to saturated, keep 0 DEG C to stir 2 lab scales, then be warming up to room temperature continuation stirring 5 hours, concentrated, add water and ethyl acetate again, extraction separatory, collects organic phase, separatory, drying, concentrated, on residuum, silicagel column is separated to obtain the bromo-2-chlorobenzene of 36g 5-also [d] oxazole.
(3) synthesis of 1-(5-bromobenzene is [d] oxazole-2-base also) piperidines-4-carboxylic acid, ethyl ester
Bromo-for 35g 5-2-chlorobenzene also [d] oxazole join 160ml N, in dinethylformamide, then add 28g Anhydrous potassium carbonate, then add 26g 4-piperidine ethyl formate, be heated to return stirring 3 lab scale, be cooled to room temperature, add water and ethyl acetate, extraction separatory, collect organic phase, drying, concentrated, residuum is crossed post separation and is obtained 42g1-(5-bromobenzene is [d] oxazole-2-base also) piperidines-4-carboxylic acid, ethyl ester.
(4) synthesis of 1-(5-bromobenzene is [d] oxazole-2-base also) piperidines-4-methane amide
20g 1-(5-bromobenzene is [d] oxazole-2-base also) piperidines-4-carboxylic acid, ethyl ester is joined in 120ml tetrahydrofuran (THF), add 120ml ammoniacal liquor again, stirring at room temperature 18 hours, add extraction into ethyl acetate again, separatory, concentrated, on residuum, silicagel column is separated to obtain 14g 1-(5-bromobenzene is [d] oxazole-2-base also) piperidines-4-methane amide.
(5) synthesis of (1-(5-bromobenzene is [d] oxazole-2-base also) piperidin-4-yl) methylamine
12g 1-(5-bromobenzene is [d] oxazole-2-base also) piperidines-4-methane amide is joined in 160ml tetrahydrofuran (THF), be cooled to 0 DEG C, slowly add 5g Lithium Aluminium Hydride, naturally stirring at room temperature is risen to 7 hours, add 1M aqueous sodium hydroxide solution, filter, mother liquor concentrations, on residuum, silicagel column is separated to obtain 6.5g (1-(5-bromobenzene is [d] oxazole-2-base also) piperidin-4-yl) methylamine.

Claims (6)

3. according to the method for claim 1-2, it is characterized in that, the reagent that described ring closure reaction prepares compound 2 used is selected from potassium ethyl xanthonate; Described chlorination is prepared compound 3 reagent used and is selected from the mixture of one or more in sulfur oxychloride, chlorine, hydrogenchloride, phosphorus oxychloride, phosphorus pentachloride; Described nucleophilic substitution reaction is prepared compound 4 alkali used and is selected from the mixture of one or more in sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, salt of wormwood, triethylamine, sodium bicarbonate, pyridine, triisopropylamine, saleratus; Described ammonolysis reaction is prepared compound 5 reagent used and is selected from one or both mixture in ammonia, ammoniacal liquor; Described reduction reaction is prepared compound 6 reductive agent used and is selected from the mixture of one or more in sodium borohydride, POTASSIUM BOROHYDRIDE, lithium borohydride, sodium cyanoborohydride, lithium aluminium hydride, borine, palladium carbon-hydrogen.
4. according to the method for claim 1-2, it is characterized in that, described ring closure reaction prepares compound 2 solvent selected from methanol used, ethanol, n-propyl alcohol, Virahol, tetrahydrofuran (THF), methylene dichloride, toluene, o-Xylol, p-Xylol, m-xylene, N, the mixture of one or more in dinethylformamide, N,N-dimethylacetamide, pyridine; Described chlorination is prepared compound 3 solvent used and is selected from methylene dichloride, trichloromethane, ethyl acetate, tetrahydrofuran (THF), toluene, tetrahydrofuran (THF), toluene, o-Xylol, p-Xylol, m-xylene, N, the mixture of one or more in dinethylformamide, N,N-dimethylacetamide, water; Described nucleophilic substitution reaction prepares compound 4 solvent selected from methanol used, ethanol, n-propyl alcohol, Virahol, tetrahydrofuran (THF), methylene dichloride, toluene, o-Xylol, p-Xylol, m-xylene, N, the mixture of one or more in dinethylformamide, N,N-dimethylacetamide, water; Described ammonolysis reaction prepares compound 5 solvent selected from methanol used, ethanol, n-propyl alcohol, Virahol, tetrahydrofuran (THF), methylene dichloride, trichloromethane, ethyl acetate, toluene, o-Xylol, p-Xylol, m-xylene, N, the mixture of one or more in dinethylformamide, N,N-dimethylacetamide, water; Described reduction reaction prepares compound 6 solvent selected from methanol used, ethanol, n-propyl alcohol, Virahol, tetrahydrofuran (THF), methylene dichloride, trichloromethane, ethyl acetate, toluene, o-Xylol, p-Xylol, m-xylene, N, the mixture of one or more in dinethylformamide, N,N-dimethylacetamide.
CN201410482468.9A2014-09-222014-09-22Preparation method of benzoxazole derivativePendingCN104311544A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN201410482468.9ACN104311544A (en)2014-09-222014-09-22Preparation method of benzoxazole derivative

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201410482468.9ACN104311544A (en)2014-09-222014-09-22Preparation method of benzoxazole derivative

Publications (1)

Publication NumberPublication Date
CN104311544Atrue CN104311544A (en)2015-01-28

Family

ID=52366885

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201410482468.9APendingCN104311544A (en)2014-09-222014-09-22Preparation method of benzoxazole derivative

Country Status (1)

CountryLink
CN (1)CN104311544A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN104788441A (en)*2015-04-022015-07-22湖南华腾制药有限公司Preparation method of polysubstituted benzoxazole derivative
CN104876919A (en)*2015-05-042015-09-02湖南华腾制药有限公司Preparation method of oxadiazole compound
CN106810543A (en)*2017-01-092017-06-09湖南华腾制药有限公司It is a kind of(The base of thiazole 5)The preparation method of benzo [d] oxazole
CN107698534A (en)*2016-08-082018-02-16湖南华腾制药有限公司A kind of preparation method of polysubstituted benzo oxazoline compound
CN107778301A (en)*2016-08-302018-03-09湖南华腾制药有限公司A kind of preparation method for substituting benzoxazoles derivative

Citations (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2008035956A1 (en)*2006-09-222008-03-27Ewha University - Industry Collaboration FoundationNew benzoxazole derivative, process for the preparation thereof and pharmaceutical composition comprising the same
CN102046622A (en)*2008-04-152011-05-04因特蒙公司Novel macrocyclic inhibitors of hepatitis C virus replication
WO2014130869A1 (en)*2013-02-222014-08-28Samumed, LlcGamma-diketones as wnt/beta -catenin signaling pathway activators

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
WO2008035956A1 (en)*2006-09-222008-03-27Ewha University - Industry Collaboration FoundationNew benzoxazole derivative, process for the preparation thereof and pharmaceutical composition comprising the same
CN102046622A (en)*2008-04-152011-05-04因特蒙公司Novel macrocyclic inhibitors of hepatitis C virus replication
WO2014130869A1 (en)*2013-02-222014-08-28Samumed, LlcGamma-diketones as wnt/beta -catenin signaling pathway activators

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JOSEPH SAM,等: "Benzoxazoles: Potent Skeletal Muscle Relaxants", 《JOURNAL OF PHARMACEUTICAL SCIENCES》*
黄宪,等: "《新编有机合成化学》", 31 January 2003*

Cited By (5)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN104788441A (en)*2015-04-022015-07-22湖南华腾制药有限公司Preparation method of polysubstituted benzoxazole derivative
CN104876919A (en)*2015-05-042015-09-02湖南华腾制药有限公司Preparation method of oxadiazole compound
CN107698534A (en)*2016-08-082018-02-16湖南华腾制药有限公司A kind of preparation method of polysubstituted benzo oxazoline compound
CN107778301A (en)*2016-08-302018-03-09湖南华腾制药有限公司A kind of preparation method for substituting benzoxazoles derivative
CN106810543A (en)*2017-01-092017-06-09湖南华腾制药有限公司It is a kind of(The base of thiazole 5)The preparation method of benzo [d] oxazole

Similar Documents

PublicationPublication DateTitle
CN104311544A (en)Preparation method of benzoxazole derivative
CN104262257A (en)Preparation method of pyrazole derivative
CN104230853B (en)A kind of preparation method of (p-methylphenyl) methylamine-N-ethylmorpholine hydrochloride
CN104292145A (en)Preparation method of 6-bromoindole derivative
CN104292179A (en)Preparation method of 2-chlorobenzo[d]oxazole-5-formaldehyde
CN104447620B (en)1-[3-[3-(4-chlorphenyl) propoxyl group] propyl group] preparation method of-piperidine hydrochlorate
CN104926775A (en)Preparation method of fluorine-containing pyran derivative
CN104387367A (en)Method for preparing disubstituted benzimidazole derivative
CN104592198A (en)Method for preparing 2-methyl-5-(piperidin-4-yl) pyrimidine
CN104277042A (en)Preparation method of imidazopyridine derivative
CN104829581A (en)Preparation method of 6-bromo pyran derivative
CN104829574A (en)8-bromo pyran derivative preparation method
CN104844549A (en)Preparation method of 7 - bromine pyran derivatives
CN104860910A (en)Preparation method of 8-fluoropyran derivative
CN104628721A (en)Preparation method of imidazo [1, 2-a] pyridine derivative
CN105001117A (en)Method for synthesizing chlorine-containing azide compound
CN104326977A (en)Preparation method of 6,7-diethyl-4-hydroxyquinoline
CN104311547A (en)Preparation method of thiazole derivative
CN104292213A (en)Preparation method of pyrimidine derivative
CN105130841A (en)Preparation method of 3-iodophenyl azide compound
CN104292157A (en)Preparation method of 1-(quinoline-4-yl) ethylamine
CN104725331A (en)Method for preparing 5-fluorobenzo[d]oxazole-2-nitrile
CN104447567B (en)A kind of preparation method of 1 substituted benzimidazole derivant
CN105061253A (en)Preparation method of bromine-containing azide
CN104262265B (en)A kind of preparation method of tetrahydro quinazoline derivative

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
WD01Invention patent application deemed withdrawn after publication

Application publication date:20150128

WD01Invention patent application deemed withdrawn after publication

[8]ページ先頭

©2009-2025 Movatter.jp